Cardiac decompensation.
D000208:Acute Disease; D000628:Aminophylline / Q000008:administration & dosage / Q000627:therapeutic use; D001243:Assisted Circulation; D002301:Cardiac Glycosides / Q000627:therapeutic use; D004077:Digoxin / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004554:Electric Countershock; D006321:Heart / Q000503:physiopathology*; D006331:Heart Diseases / Q000150:complications; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D009020:Morphine / Q000627:therapeutic use; D010042:Ouabain / Q000008:administration & dosage / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010646:Phentolamine / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000628:therapy; D013610:Tachycardia / Q000628:therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D002301:Cardiac Glycosides; D004232:Diuretics; D014665:Vasodilator Agents; D000628:Aminophylline; D010042:Ouabain; D004077:Digoxin; D009020:Morphine; D010646:Phentolamine